HOME >> BIOLOGY >> NEWS
First Study To Take Bacteria Directly From Patients' Mouths Further Supports Possible Link Between Gum And Heart Disease

By taking bacteria samples directly from patients' mouths and exposing the samples to human blood platelets, researchers at Temple Univeristy Schools of Dentistry and Medicine have further confirmed a possible link between periodontal bacteria and heart disease.

In recent weeks, a great deal of media attention has been focused on this possible relationship. In fact, since the early 1990s, preliminary studies at other universities have used laboratory strains of mouth bacteria and population data to show this possible link.

Temple's study is the first to take a large number of dental plaque bacteria directly from the mouths of patients with severe periodontal disease and test their effect on blood platelets.

"Almost immediately after we exposed human blood platlets to the dental plaque bacteria, the platelets began to clump together," says Dr. Eugene J. Whitaker, associate professor of Dentistry and lead investigator. "And, out of all the periodontal bacteria we tested, Porphyromanas gingivalis was the only one to cause this clumping, which is a key step in formation of bloodstream thrombi (blockage)."

Porphyromanas gingivalis is the most important bacterial cause of destructive gum diseases in adults. The Temple research findings further support and expand a possible link between periodontal disease and development of athrosclerotic heart disease, a condition resulting from plaque build-up and constriction of coronary heart arteries, and strokes affecting the brain.

"The importance of our findings is that at least 36 million American adults have some form of destructive periodontal disease, which leads to loosening and loss of teeth," says Dr. Thomas E. Rams, a co-investigator and chairman of Temple's Department of Periodontology. "Porphyromanas gingivalis is very frequently in dental plaque causing this disease. These people may be at increased risk
'"/>

Contact: Andrew Smith
asmith01@nimbus.ocis.temple.edu
(215) 707-8229
Temple University Health System
27-Feb-1998


Page: 1 2

Related biology news :

1. First glimpse of DNA binding to viral enzyme
2. First clinical study of new pediatric croup vaccine shows safety, tolerability in adults
3. 2nd media alert First Scientific Conference on Childhood Leukaemia
4. First International Scientific Conference on Childhood Leukaemia
5. First ever standards linking climate change, biodiversity and poverty seek global peer review
6. First genetic comparison of purebred domestic dogs produces surprises
7. First time in the U.S.: Saint Louis University tests third-generation vaccine against smallpox
8. First target for childhood malaria vaccine
9. First study of resveratrol dietary supplement finds effect on breast and prostate cancers unlikely
10. First flavors form a lasting impression
11. STN International launches Derwent World Patents Index First View

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/26/2017)... , Jan. 26, 2017  Crossmatch, a leading provider ... new solution aimed at combatting fraud, waste and abuse ... introduced at the Action on Disaster Relief conference in ... point for UN agencies and foreign assistance organizations throughout ... waste and abuse are a largely unacknowledged problem in ...
(Date:1/24/2017)... 24, 2017 Biopharm Reports has carried ... use of nuclear magnetic resonance spectroscopy (NMR). This ... profiled current practices, developments, trends and end-user plans ... growth and opportunities. These areas include growth in ... needs and innovation requirements, hyphenated NMR techniques, main ...
(Date:1/21/2017)... , Jan 20, 2017 Research and ... Biometrics Market 2017-2021" report to their offering. ... The global voice recognition biometrics ... 2017-2021. The report covers the present scenario and ... 2017-2021. To calculate the market size, the report considers the revenue ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... ROCHESTER, Minn. , Feb. 23, 2017 /PRNewswire/ ... a new product line of oncolytic vaccinia viruses ... Genelux Corporation as part of Genelux,s proprietary, vaccinia ... "We are excited to enter into a partnership ... time, selected oncolytic vaccinia viruses for use in ...
(Date:2/23/2017)... ... 23, 2017 , ... The Greater Gift Initiative, Inc , (GGI) a ... Research . GGI's mission is to advance global health and highlight the greater good ... honor of each clinical trial volunteer. The vision of GGI is to serve as ...
(Date:2/22/2017)... Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on ... companion animals, will host a live conference call on Tuesday, ... results from the fourth quarter and full year ended December ... access the audio webcast or use the conference ... ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... provider of women’s health, primary care, and specialty education, announced today it ... Education (ACCME). ACCME’s Accreditation with Commendation is a six-year accreditation and is ...
Breaking Biology Technology:
Cached News: